Trials / Completed
CompletedNCT01318954
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 17 (actual)
- Sponsor
- Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate whether exhaled nitric oxide levels are affected by allergen immunotherapy ("allergy shots"). The investigators' hypothesis is that successful allergen immunotherapy may be accompanied by decreased exhaled nitric oxide levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Allergen immunotherapy |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2011-03-21
- Last updated
- 2015-10-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01318954. Inclusion in this directory is not an endorsement.